4.0
Jul 15, 2021
Current employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
The company is still small and therefore there’s opportunity to make a tangible impact. Lots of very experienced, talented and great colleagues. The benefits are very good as well and there’s good emphasis on career development
Cons
Lots of legacy thinking from the old Novartis crew or CSL, both much larger and potentially slower to action organizations. Seqirus leadership is a bit risk resistant and that’s critical at a time when the market is so dynamic